Matched comparison of therapeutic DLI and second allogeneic transplantation after relapse of acute leukemia or MDS - Top-Institutions - MDSpire

Matched comparison of therapeutic DLI and second allogeneic transplantation after relapse of acute leukemia or MDS

  • By

  • Alexander C. Angleitner

  • Markus Maulhardt

  • Justin Hasenkamp

  • Judith Büntzel

  • Gerald Wulf

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

    N/A, N/A

    Key Differentiators

    • Hematology

  • #2

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    N/A, N/A

    Key Differentiators

    • Hematology

  • #3

    Center for International Blood and Marrow Transplant Registry
    Center for International Blood and Marrow Transplant Registry

    N/A, N/A

    Key Differentiators

    • Hematology

Original Source(s)

Matched comparison of therapeutic DLI and second allogeneic transplantation after relapse of acute leukemia or MDS

  • by Alexander C. Angleitner, Markus Maulhardt, Justin Hasenkamp, Judith Büntzel, Gerald Wulf

  • June 11, 2026

Related Content

Preliminary evaluation of DeepSeek-R1 and GPT-5.3 in selected PET/CT clinical scenarios: patient preparation, report interpretation, and diagnostic reasoning

Preoperative electrolyte-based metabolic biomarkers for prognostic assessment in gastric cancer: a multicenter study

Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer